Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Market Closed -
OTC Markets
18:16:39 29/05/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 02/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.82M 1.71M 1.56M 2.93M 204M 2.97M 20.15M 7.86M 102M 7.99M 7.82M 338M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 5.78M 5.4M 4.95M 9.28M 645M 9.41M 63.85M 24.9M 324M 25.32M 24.77M 1.07B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 6 months | -50.00% |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.03 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Madson
DFI | Director of Finance/CFO | 65 | 01/04/2015 |
Lisa Ackermann
SAM | Sales & Marketing | 53 | 16/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 29/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 03/10/2005 |
| Director/Board Member | 59 | 06/08/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | -.--% | 2.13K | ||
| -0.20% | +4.82% | -16.08% | +34.31% | 3.34B | ||
| +0.95% | +0.95% | +30.86% | +1,368.14% | 3.03B | ||
| -4.81% | -3.07% | +25.17% | +415.95% | 2.27B | ||
| -0.65% | -0.32% | -34.75% | -16.64% | 1.7B | ||
| +1.45% | +6.06% | +147.06% | +536.36% | 1.59B | ||
| -0.68% | -2.40% | +10.91% | +12.62% | 616M | ||
| 0.00% | +14.71% | +29.42% | +40.62% | 363M | ||
| +3.97% | +3.60% | +51.58% | +69.41% | 205M | ||
| -0.71% | +2.21% | +46.32% | +85.33% | 122M | ||
| Average | -0.07% | +1.60% | +29.05% | +254.61% | 1.32B | |
| Weighted average by Cap. | -0.54% | -0.14% | +23.06% | +458.96% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.12M 13.21M 12.09M 22.7M 1.58B 23M 156M 60.87M 792M 61.9M 60.55M 2.62B | 14.01M 12M 11.23M 10.28M 19.29M 1.34B 19.55M 133M 51.74M 673M 52.61M 51.47M 2.23B |
| Net income | -4.29M -3.68M -3.44M -3.15M -5.91M -411M -5.99M -40.64M -15.85M -206M -16.12M -15.77M -682M | -7.61M -6.52M -6.1M -5.58M -10.48M -728M -10.61M -72.04M -28.09M -366M -28.57M -27.95M -1.21B |
| Net Debt | 3.04M 2.61M 2.44M 2.23M 4.19M 291M 4.25M 28.82M 11.24M 146M 11.43M 11.18M 484M | 4.62M 3.95M 3.7M 3.39M 6.35M 442M 6.44M 43.7M 17.04M 222M 17.33M 16.95M 734M |
Employees
61
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















